John Schieszer, MA

Contributing Writer https://www.cancertherapyadvisor.com

John Schieszer is an award winning medical journalist who produces The Medical Minute podcasts. John received his BA in journalism from the University of Missouri-Columbia School of Journalism and his MA in english from the University of Missouri-St. Louis. In 1990, John was awarded the Case Western Reserve University School of Medicine’s Third Annual Fellowship for Journalists in Biomedical Research. In 1992, he completed a Medical Fellowship at the Marine Biological Laboratories in Woods Hole, Massachusetts.

All articles by John Schieszer, MA

Gastrointestinal Cancers

Combating Colon Cancer Based on Genetic Mutations

John Schieszer, MA

June 4, 2013

Targeted therapy based on genetic mutations may soon become the standard of care for colorectal cancer.

Gastrointestinal Cancers

New Approaches to Liver Cancer Offering New Hope

John Schieszer, MA

May 9, 2013

Recent research on liver cancer prevention and treatment is showing promise in combating the disease.

Oncology Features

Prescribing Exercise Before and During Cancer Treatment May Lead to Better Outcomes

John Schieszer, MA

April 25, 2013

Certain forms of exercise can help combat fatigue and other side effects from cancer treatment, leading to improved outcomes for patients.

Breast Cancer

A Growing Concern Over Increased Cardiovascular Disease Risk in Breast Cancer Survivors

John Schieszer, MA

April 16, 2013

Patients with breast cancer are living longer after treatment; however, with these therapies comes risk for cardiovascular problems.

Lung Cancer

Prognosis is Poorer in Patients with Lung Cancer Who Are HIV-Infected

John Schieszer, MA

March 26, 2013

Even when accounting for competing risks, data shows that patients with lung cancer who are HIV-infected have a worse prognosis than those who are noninfected.

Genitourinary Cancers Symposium 2013

GU Symposium Report: New Drug Combinations Improve Prostate Cancer Outcomes

John Schieszer, MA

March 5, 2013

Survival rates rise as newer agents are used in combination therapies for patients with advanced prostate cancer.

Side Effect Management

New Studies Help Better Define Cognitive Changes Due to Cancer Therapies

John Schieszer, MA

February 27, 2013

The latest research on chemobrain explores aspects of cancer treatment other than chemotherapy that may affect brain function.

Oncology Features

U.S. Cancer Rates Reach Milestone as Deaths Decline

John Schieszer, MA

February 7, 2013

Since their peak in 1991, deaths from cancer have dropped 20%, according to the cancer statistics report published annually by the American Cancer Society.

Prostate Cancer

Radiotherapy Following Prostatectomy May Have Lasting Benefits

John Schieszer, MA

January 17, 2013

Conventional postoperative radiotherapy may significantly improve biochemical progression-free survival and local control compared with a wait-and-see policy in men who undergo radical prostatectomy.

General Oncology

HIV-Infected Population May Have Higher Cancer Burden and Lower Cancer Survival Rates

John Schieszer, MA

December 20, 2012

Experts discuss the available evidence that patients with HIV have an increased risk of certain cancer types as well as worse survival.

Next post in General Oncology